Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Allogene TherapeuticsAudentes TherapeuticsAblynxSpark TherapeuticsProteon Therapeutics
SymbolNASDAQ:ALLONASDAQ:BOLDOTCMKTS:ABLYFNASDAQ:ONCENASDAQ:PRTO
Price Information
Current Price$19.92$59.97$50.63$113.57$21.90
52 Week RangeBuyHoldN/AHoldHold
Analyst Ratings
Consensus RecommendationBuyHoldN/AHoldHold
Consensus Price Target$34.80$50.75N/A$114.50$1.00
% Upside from Price Target74.70% upside-15.37% downsideN/A0.82% upside-95.43% downside
Trade Information
Market Cap$2.53 billion$2.77 billion$3.81 billion$4.37 billion$485.72 million
Beta0.552.181.992.050.6
Average Volume856,9641,504,389N/A419,9331,113,217
Sales & Book Value
Annual RevenueN/AN/A$62.73 million$64.72 millionN/A
Price / SalesN/AN/A60.7467.59N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.16 per share($7.48) per share$2.71 per share$13.15 per share($0.06) per share
Price / BookN/AN/A18.688.64N/A
Profitability
Net Income$-184,590,000.00$-128,820,000.00$-122,670,000.00$-78,820,000.00$-20,730,000.00
EPS($1.83)($3.40)N/A($2.11)($1.15)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-358.41%N/A
Return on Equity (ROE)-28.56%N/AN/A-59.10%N/A
Return on Assets (ROA)-25.49%-38.00%N/A-33.13%-118.68%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/AN/A0.35%N/A
Current Ratio16.46%12.80%N/A4.67%5.98%
Quick Ratio16.46%12.79%N/A4.35%5.98%
Ownership Information
Institutional Ownership Percentage57.34%96.33%N/A88.37%23.03%
Insider Ownership Percentage36.50%5.30%N/A6.00%45.70%
Miscellaneous
Employees122207N/A36817
Shares Outstanding124.91 million46.27 million75.25 million38.52 million22.18 million
Next Earnings Date5/5/2020 (Estimated)N/AN/AN/A5/6/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel